Chemours Q4 revenue falls

Reuters

Feb 20

Chemours Q4 revenue falls

Overview

Chemicals firm's Q4 revenue fell 2% yr/yr, driven by volume declines
Adjusted EBITDA for Q4 decreased 24% yr/yr

Outlook

Company projects full-year 2026 net sales growth of 3 to 5%
Chemours anticipates full-year 2026 adjusted EBITDA between $800 mln and $900 mln

Result Drivers

TSS GROWTH - Record Q4 performance in TSS driven by 37% growth in Opteon™ Refrigerants
TT DECLINE - TT segment sales decreased due to lower TiO2 pigment pricing and volume, especially in non-western markets

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
FY Sales	Meet	$5.80 bln	$5.80 bln (9 Analysts)
FY Adjusted EPS	Miss	$0.95	$0.96 (9 Analysts)
FY Adjusted Net Income	Miss	$143 mln	$145.74 mln (9 Analysts)
FY Adjusted EBITDA	Miss	$742 mln	$755.21 mln (9 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy."
Wall Street's median 12-month price target for Chemours Co is $15.00, about 29.1% below its February 18 closing price of $21.15
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 7 three months ago

Press Release: ID:nPnQ3zrFa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2612235035"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612235035\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612235035?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 05:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612235035","market":"nz","top_or_hot":-1,"title":"Chemours Q4 revenue falls","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Chemours Q4 revenue falls</title></head><body><p><span>Overview</span></p><ul><li><p>Chemicals firm's Q4 revenue fell 2% yr/yr, driven by volume declines</p></li><li><p>Adjusted EBITDA for Q4 decreased 24% yr/yr</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company projects full-year 2026 net sales growth of 3 to 5%</p></li><li><p>Chemours anticipates full-year 2026 adjusted EBITDA between $800 mln and $900 mln</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>TSS GROWTH - Record Q4 performance in TSS driven by 37% growth in Opteon™ Refrigerants</p></li><li><p>TT DECLINE - TT segment sales decreased due to lower TiO2 pigment pricing and volume, especially in non-western markets</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>FY Sales</p></td><td><p>Meet</p></td><td><p>$5.80 bln</p></td><td><p>$5.80 bln (9 Analysts)</p></td></tr><tr><td><p>FY Adjusted EPS</p></td><td><p>Miss</p></td><td><p>$0.95</p></td><td><p>$0.96 (9 Analysts)</p></td></tr><tr><td><p>FY Adjusted Net Income</p></td><td><p>Miss</p></td><td><p>$143 mln</p></td><td><p>$145.74 mln (9 Analysts)</p></td></tr><tr><td><p>FY Adjusted EBITDA</p></td><td><p>Miss</p></td><td><p>$742 mln</p></td><td><p>$755.21 mln (9 Analysts)</p></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy\", 4 \"hold\" and 1 \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the diversified chemicals peer group is \"buy.\"</p></li><li><p>Wall Street's median 12-month price target for Chemours Co is $15.00, about 29.1% below its February 18 closing price of $21.15</p></li><li><p>The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 7 three months ago</p></li></ul><p>Press Release: <span>ID:nPnQ3zrFa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chemours Q4 revenue falls</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChemours Q4 revenue falls\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-20 05:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Chemours Q4 revenue falls</title></head><body><p><span>Overview</span></p><ul><li><p>Chemicals firm's Q4 revenue fell 2% yr/yr, driven by volume declines</p></li><li><p>Adjusted EBITDA for Q4 decreased 24% yr/yr</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company projects full-year 2026 net sales growth of 3 to 5%</p></li><li><p>Chemours anticipates full-year 2026 adjusted EBITDA between $800 mln and $900 mln</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>TSS GROWTH - Record Q4 performance in TSS driven by 37% growth in Opteon™ Refrigerants</p></li><li><p>TT DECLINE - TT segment sales decreased due to lower TiO2 pigment pricing and volume, especially in non-western markets</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>FY Sales</p></td><td><p>Meet</p></td><td><p>$5.80 bln</p></td><td><p>$5.80 bln (9 Analysts)</p></td></tr><tr><td><p>FY Adjusted EPS</p></td><td><p>Miss</p></td><td><p>$0.95</p></td><td><p>$0.96 (9 Analysts)</p></td></tr><tr><td><p>FY Adjusted Net Income</p></td><td><p>Miss</p></td><td><p>$143 mln</p></td><td><p>$145.74 mln (9 Analysts)</p></td></tr><tr><td><p>FY Adjusted EBITDA</p></td><td><p>Miss</p></td><td><p>$742 mln</p></td><td><p>$755.21 mln (9 Analysts)</p></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy\", 4 \"hold\" and 1 \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the diversified chemicals peer group is \"buy.\"</p></li><li><p>Wall Street's median 12-month price target for Chemours Co is $15.00, about 29.1% below its February 18 closing price of $21.15</p></li><li><p>The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 7 three months ago</p></li></ul><p>Press Release: <span>ID:nPnQ3zrFa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4098","symbol_name":"多种化学制品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL1N3ZF1DU:1","article_id":"2612235035","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612235035","pubTimestamp":1771537672,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Chemours Q4 revenue fallsOverviewChemicals firm's Q4 revenue fell 2% yr/yr, driven by volume declinesAdjusted EBITDA for Q4 decreased 24% yr/yrOutlookCompany projects full-year 2026 net sales growth o","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4098":"多种化学制品","CC":"Chemours Company"},"translate_title":"科慕第四季度收入下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CC":0.9},"content_text":"Chemours Q4 revenue fallsOverviewChemicals firm's Q4 revenue fell 2% yr/yr, driven by volume declinesAdjusted EBITDA for Q4 decreased 24% yr/yrOutlookCompany projects full-year 2026 net sales growth of 3 to 5%Chemours anticipates full-year 2026 adjusted EBITDA between $800 mln and $900 mlnResult DriversTSS GROWTH - Record Q4 performance in TSS driven by 37% growth in Opteon™ RefrigerantsTT DECLINE - TT segment sales decreased due to lower TiO2 pigment pricing and volume, especially in non-western marketsKey DetailsMetricBeat/MissActualConsensus EstimateFY SalesMeet$5.80 bln$5.80 bln (9 Analysts)FY Adjusted EPSMiss$0.95$0.96 (9 Analysts)FY Adjusted Net IncomeMiss$143 mln$145.74 mln (9 Analysts)FY Adjusted EBITDAMiss$742 mln$755.21 mln (9 Analysts)Analyst CoverageThe current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy\", 4 \"hold\" and 1 \"sell\" or \"strong sell\"The average consensus recommendation for the diversified chemicals peer group is \"buy.\"Wall Street's median 12-month price target for Chemours Co is $15.00, about 29.1% below its February 18 closing price of $21.15The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 7 three months agoPress Release: ID:nPnQ3zrFaFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}